Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

ArKal Medical (Fremont, CA) developer of a continuous glucose monitoring system, closed a $17.5M Series B financing. Participants include Thomas McNerney & Partners, Delphi Ventures and MedVenture Associates.

Calibra Medical (Seattle, WA) development-stage medical device company focused on insulin delivery solutions, closed a $35M Series B financing. Participants include Canaan Partners, InterSouth Partners, Skyline Ventures, Frazier Healthcare Ventures, and Three Arch Partners.

GluMetrics (Irvine, CA) development-stage medical device company focused on glucose monitoring devices, closed a $20.1M Series C financing. Participants include New Leaf Venture Partners, Versant Ventures and Advanced Technology Ventures.

Tandem Diabetes Care (San Diego, CA) focused on medical devices for diabetes closed a $13.1 Series B financing. Participants include Domain Associates, TPG Biotech and Second Technology Capital Investors.

Seattle Medical Technologies (Seattle, Washington) medical device company focused on diabetes, closed a $21M Series B financing. Participants include Canaan Partners, Skyline Venture Partners, Frazier Healthcare Ventures and Three Arch Partners.

enGene (Canada) protein drug delivery system targeting insulin regulation for diabetics, closed a $6.4M Series A financing. Participants include Saad Investments and Masa Life Science Ventures.

AgaMatrix (Salem, NH) maker of blood glucose monitoring systems that provide results to help users better manage their diabetes closed a $23.7M Series C financing. Participants include Ferrer Freeman & Co.

« Previous Page  Next Entries »

to top of page...